High-Resolution, 18F-fluciclovine PET-MRI for Mapping Prostate Cancer in Patients Considering Focal High-Intensity Focused Ultrasound (HIFU) Therapy
Status: Active, no longer recruiting
Phase of Trial: Phase 0
Latest Information Update: 05 Dec 2019
Price : $35 *
At a glance
- Drugs Fluciclovine 18F (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 18 Jun 2019 Status changed from recruiting to active, no longer recruiting.
- 18 Dec 2017 Status changed from not yet recruiting to recruiting.
- 06 Nov 2017 Planned End Date changed from 1 Sep 2020 to 1 Dec 2020.